2004
DOI: 10.1007/s11908-004-0055-9
|View full text |Cite
|
Sign up to set email alerts
|

Update on the virologic and immunologic response to highly active antiretroviral therapy

Abstract: Highly active antiretroviral therapy (HAART) delays clinical progression by suppressing viral replication, measured by a substantial reduction in HIV RNA, allowing the immune system to reconstitute, measured in most studies by an increase in CD4 cells. These virologic and immunologic consequences do not occur uniformly among HAART users. Markers of HIV disease stage at the time of HAART initiation are critical determinants of the progression while receiving HAART. In this report, we review studies describing t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

2007
2007
2017
2017

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 50 publications
(23 reference statements)
1
11
0
Order By: Relevance
“…CD4 counts started to increase before HIV virus was completely suppressed (time point 0). This is consistent with findings from other studies, that is, CD4 cells may increase after HAART for patients who do not fully suppress the virus, because the level of viral load is decreasing [Jacobson, Phair and Yamashita (2004)]. However, Figure 6(a), also suggests that the decreasing trend for HCV-negative patients ends earlier than HCV-positive patients when HAART started to be initiated.…”
Section: Population Estimatessupporting
confidence: 91%
See 1 more Smart Citation
“…CD4 counts started to increase before HIV virus was completely suppressed (time point 0). This is consistent with findings from other studies, that is, CD4 cells may increase after HAART for patients who do not fully suppress the virus, because the level of viral load is decreasing [Jacobson, Phair and Yamashita (2004)]. However, Figure 6(a), also suggests that the decreasing trend for HCV-negative patients ends earlier than HCV-positive patients when HAART started to be initiated.…”
Section: Population Estimatessupporting
confidence: 91%
“…HIV dynamics following initiation of antiviral therapy. The widespread use of highly active antiretroviral therapies (HAART) against HIV in the United States has resulted in reducing the burden of HIV-related morbidity and mortality [Jacobson, Phair and Yamashita (2004)]. HIV dynamics following HAART are usually studied in short-term clinical trials with frequent data collection design.…”
Section: Introductionmentioning
confidence: 99%
“…MACS design and methods have been described previously (2224). In brief, at each semiannual study visit, participants complete a standardized questionnaire soliciting information about their medical history, HIV treatment, behaviors, depression and daily activities, undergo physical examinations and have blood and urine specimens collected for laboratory testing and storage (25). Study questionnaires are available at http://aidscohortstudy.org/.…”
Section: Methodsmentioning
confidence: 99%
“…Study participants returned every 6 months for study evaluations that include a standardized interview, physical examinations, questionnaires (including SF-36 45 and items of the Centers for Epidemiologic Studies Depression Scale (CES-D) 46), and collection of blood for laboratory testing and storage in local and national repositories 47. T-lymphocyte subsets were measured at each MACS center using a standardized flow cytometry protocol.…”
Section: Methodsmentioning
confidence: 99%